CIK 0001410098
- Non-accelerated filer
CorMedix Inc.
Sign in to watch- Ticker
- CRMD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 908-517-9500
- Business address
- 389 INTERPACE PKWY, SUITE 450, PARSIPPANY, NJ, 07054
- Open-market buys, last 90 days
- $588,195
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$588,195. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-26 | Duncan Gregory Scott Director | Grant or award | +30,453 | 68,786 | ||
| 2025-09-16 | Duncan Gregory Scott Director | Exercise or conversion | +13,333 | $8.32 | $111K | 38,333 |
| 2025-09-16 | Duncan Gregory Scott Director | Exercise or conversion · Stock Option (Right to Buy Common Stock) | −13,333 | 6,667 | ||
| 2025-01-17 | Duncan Gregory Scott Director | Grant or award | +25,000 | 25,000 | ||
| 2024-03-05 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +30,000 | 30,000 | ||
| 2023-01-14 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2022-02-22 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2021-01-11 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2020-11-02 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +20,000 | 20,000 | ||
| 2020-11-02 | Duncan Gregory Scott Director | Grant or award · Stock Option (Right to Buy Common Stock) | +2,500 | 2,500 |
Page 1 of 1 · 10 trades